23:46 , Aug 5, 2019 |  BC Extra  |  Financial News

Aug. 5 Financial Quick Takes: Biotech tumbles with broader markets; plus Exo, 3-V and more

Biotech stocks take a hit  U.S. biotech stocks fell in line with the broader markets Monday, with the NASDAQ Composite, NYSE Arca Biotechnology Index (BTK), SPDR S&P Biotech ETF (XBI) and BioCentury 100 each losing...
18:38 , Feb 8, 2019 |  BioCentury  |  Finance

Extending a Bold vision for Longevity

After making a handful of longevity-related investments as a partner at Bold Capital, Sergey Young is seeking to invest about $100 million via the Longevity Vision Fund, a new vehicle dedicated solely to the field...
18:40 , Feb 4, 2019 |  BC Extra  |  Financial News

Longevity Vision Fund launches with $100M

The Longevity Vision Fund launched with $100 million to invest in therapeutics and complementary technologies intended to extend the period of healthy human life. Founder Sergey Young is also a partner at Bold Capital Partners...
00:06 , Sep 28, 2018 |  BC Innovations  |  Emerging Company Profile

GDF11 against aging

Harvard University spinout Elevian Inc. is developing a regenerative platform around GDF11 to treat age-related diseases, including Alzheimer's disease. The company, which emerged from stealth on Sept. 6, aims to modulate the protein’s pathway with...
19:28 , Sep 7, 2018 |  BC Week In Review  |  Financial News

Anti-aging Elevian debuts with $5.5M seed funding

Regenerative medicine company Elevian Inc. (Allston, Mass.) launched on Sept. 6 with $5.5 million in seed funding from Bold Capital, WTI, Stanford StartX fund, Longevity Fund, Kizoo Ventures, Thynk Capital and additional undisclosed investors. Elevian...
19:58 , Jun 15, 2018 |  BC Week In Review  |  Company News

Wuxi to use Insilico's AI platform to speed drug discovery

WuXi AppTec Co. Ltd. (Shanghai:603259) led a venture round for Insilico Medicine Inc. (Baltimore, Md.) and partnered with the artificial intelligence company to discover and develop new molecules. Insilico CEO Alex Zhavoronkov told BioCentury it...
14:04 , Jun 11, 2018 |  BC Extra  |  Financial News

WuXi AppTec, Insilico enter R&D, equity deal

WuXi AppTec Co. Ltd. (Shanghai:603259) led a venture round for Insilico Medicine Inc. (Baltimore, Md.) and partnered with the artificial intelligence company to discover and develop new molecules. Insilico CEO Alex Zhavoronkov told BioCentury it...